We are live on !
Find out more
Almitas Capital Portfolio holdings
AUM
$444M
Turnover
31.29%
1-Year Est. Return
1.32%
This Fund
S&P 500
This Quarter Est. Return
+3.96%
1 Year Est. Return
+1.32%
3 Year Est. Return
+98.67%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$444M
AUM Growth
+$26.5M
(+6.3%)
Cap. Flow
+$15.1M
Cap. Flow % of AUM
Cap. Flow %
3.4%
Top 10 Holdings %
Top 10 Hldgs %
53.27%
Holding
163
New
34
Increased
36
Reduced
29
Closed
17
Avg Time Held
0.7
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Guggenheim Strategic Opportunities Fund
GOF
|
+$16.4M |
| 2 |
Cornerstone Strategic Investment Fund
CLM
|
+$8.51M |
| 3 |
ASA Gold and Precious Metals
ASA
|
+$6.98M |
| 4 |
BlackRock Capital Allocation Term Trust
BCAT
|
+$6.75M |
| 5 |
FS Specialty Lending Fund
FSSL
|
+$5.35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amylyx Pharmaceuticals
AMLX
|
+$23.7M |
| 2 |
Fidelity Wise Origin Bitcoin Fund
FBTC
|
+$17.4M |
| 3 |
Tortoise Energy Infrastructure Corp
TYG
|
+$6.94M |
| 4 |
Design Therapeutics
DSGN
|
+$5.96M |
| 5 |
AN2 Therapeutics
ANTX
|
+$5.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 76.84% |
| 2 | Financials | 9.4% |
| 3 | Healthcare | 4.94% |
| 4 | Real Estate | 4.3% |
| 5 | Consumer Discretionary | 2.78% |
Similar funds
CSWG
LFGO
DA
Almitas Capital's Q3 2026 Portfolio in Review
As of Q3 2026, Almitas Capital held 163 positions worth $444M, up 6.3% from $417M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Almitas Capital deployed $15.1M of net new capital in Q3 2026, opening 34 new positions and adding to 36 existing holdings. Its largest new stake was Guggenheim Strategic Opportunities Fund: 1,650,819 shares worth $14M.
By sector, the portfolio is most concentrated in Miscellaneous at 77% of assets, up from 69% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Amylyx Pharmaceuticals, an estimated $23.7M trimmed.
- Almitas Capital's largest Q3 2026 buy was Guggenheim Strategic Opportunities Fund: 1,650,819 shares worth $14M.
- Almitas Capital added most to Cornerstone Strategic Investment Fund in Q3 2026, an estimated $8.51M increase.
- Almitas Capital's biggest Q3 2026 reduction was Amylyx Pharmaceuticals, cutting an estimated $23.7M.
- Almitas Capital fully exited Tortoise Energy Infrastructure Corp in Q3 2026, selling an estimated $6.94M.
- Almitas Capital's ten largest holdings make up 53% of its $444M portfolio in Q3 2026.
- Almitas Capital opened 34 new positions and closed 17 in Q3 2026.
- Almitas Capital's portfolio value rose 6.3% quarter-over-quarter to $444M.
Based on Almitas Capital's 13F filing for Q3 2026, filed 17 Nov 2026.